1. Home
  2. ADMA vs NOVT Comparison

ADMA vs NOVT Comparison

Compare ADMA & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • NOVT
  • Stock Information
  • Founded
  • ADMA 2004
  • NOVT 1968
  • Country
  • ADMA United States
  • NOVT United States
  • Employees
  • ADMA N/A
  • NOVT N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • NOVT Industrial Machinery/Components
  • Sector
  • ADMA Health Care
  • NOVT Miscellaneous
  • Exchange
  • ADMA Nasdaq
  • NOVT Nasdaq
  • Market Cap
  • ADMA 5.1B
  • NOVT 4.6B
  • IPO Year
  • ADMA N/A
  • NOVT N/A
  • Fundamental
  • Price
  • ADMA $19.83
  • NOVT $122.16
  • Analyst Decision
  • ADMA Strong Buy
  • NOVT Hold
  • Analyst Count
  • ADMA 4
  • NOVT 1
  • Target Price
  • ADMA $24.25
  • NOVT $160.00
  • AVG Volume (30 Days)
  • ADMA 3.4M
  • NOVT 317.1K
  • Earning Date
  • ADMA 05-07-2025
  • NOVT 05-06-2025
  • Dividend Yield
  • ADMA N/A
  • NOVT N/A
  • EPS Growth
  • ADMA N/A
  • NOVT 1.57
  • EPS
  • ADMA 0.84
  • NOVT 1.95
  • Revenue
  • ADMA $459,381,000.00
  • NOVT $951,695,000.00
  • Revenue This Year
  • ADMA $19.45
  • NOVT $5.66
  • Revenue Next Year
  • ADMA $28.10
  • NOVT $7.58
  • P/E Ratio
  • ADMA $23.74
  • NOVT $63.50
  • Revenue Growth
  • ADMA 62.23
  • NOVT 6.52
  • 52 Week Low
  • ADMA $9.40
  • NOVT $98.76
  • 52 Week High
  • ADMA $25.67
  • NOVT $187.12
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 46.14
  • NOVT 46.00
  • Support Level
  • ADMA $19.28
  • NOVT $118.22
  • Resistance Level
  • ADMA $20.14
  • NOVT $124.62
  • Average True Range (ATR)
  • ADMA 0.74
  • NOVT 2.64
  • MACD
  • ADMA -0.09
  • NOVT -0.55
  • Stochastic Oscillator
  • ADMA 55.14
  • NOVT 20.25

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About NOVT Novanta Inc.

Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.

Share on Social Networks: